Compass Ion Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Compass Ion Advisors's AMGN Position: Q1 2026 in Review
Compass Ion Advisors increased its Amgen (AMGN) stake by 0.27% in Q1 2026, buying an estimated $5.35K and bringing the position to 5,566 shares worth $1.96M. The position accounts for 0.19% of the portfolio, ranked #67.
Compass Ion Advisors first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Compass Ion Advisors held 5,566 shares of Amgen worth $1.96M as of Q1 2026.
- Compass Ion Advisors bought 15 Amgen shares in Q1 2026, an estimated $5.35K.
- Amgen made up 0.19% of Compass Ion Advisors's portfolio in Q1 2026, its #67 holding.
- Compass Ion Advisors first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Compass Ion Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.